BioSpace News Archive

Orexo AB, invites investors, analysts, and media to attend a teleconference on Thursday October 1, at 3 pm CET.

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved ULTOMIRIS® (ravulizumab) for adults and children living with atypical hemolytic uremic syndrome (aHUS).

LB Pharmaceuticals Inc, a biotechnology company focused on developing and commercializing novel and improved versions of successful CNS treatments, today announced the closing of a $10.0 million convertible note offering through a private placement to existing and new investors.

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it has finalized an amendment to its distribution agreement with Puregraft LLC for Puregraft’s line of products for autologous adipose tissue harvesting and redistribution.

Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases, today announced the appointment of Cynthia Feldmann to its Board of Directors.

Research allows Company to explore potential benefits of microgravity for development of its artificial retina, and lays the groundwork for future missions

PCT LTD (OTC Pink: “PCTL”) is releasing the agenda and additional information for their scheduled shareholders conference call which will take place on Tuesday, September 29th at 4:30pm EST.

Newlight Technologies, Inc., a biotechnology company based in Southern California dedicated to making materials that improve the environment, has worked with the Carbon Trust, an independent organization with a mission to accelerate the move to a sustainable, low carbon economy, to calculate and certify the cradle-to-gate carbon footprint of Newlight’s AirCarbon product

Shape Memory Medical Inc., developer of innovative therapies for cardiovascular and neurovascular markets, is pleased to announce and welcome Mary Dennehy as Vice President of Marketing.

Happiness Biotech Group Limited (the “Company” or Nasdaq: HAPP), an innovative China -based nutraceutical and dietary supplements producer, announced today that the Company has entered into certain securities purchase agreement with three non-U.S. investors, pursuant to which the Company agreed to sell 900,000 ordinary shares a